The Pierre Fabre laboratory filed a complaint against X following a cyberattack on March 31, which caused the shutdown of a large part of the production of its pharmaceutical and cosmetic products.
"
A complaint against X has been filed by the Pierre Fabre laboratories
," the communications department of the third French laboratory, headquartered in Castres, Tarn, told AFP on Wednesday.
The complaint targets a "
fraudulent introduction of data into an automated processing system
", according to the Castres prosecutor's office.
Read also: The pharmaceutical group Pierre Fabre victim of a cyberattack, factories closed
Disruptions continued to affect production sites, but a return to normal is expected in the coming days, according to the company.
In a statement the day after the attack, the pharmaceutical group announced that the spread of the computer virus was "
completely contained
".
Pierre Fabre, an unlisted group, achieved a turnover of 2.2 billion euros in 2020, of which 65% abroad.
It has several business segments, dermo-cosmetics constituting the majority of its sales (around 60%).
Pierre Fabre, pharmacist and founder in 1962 of this company, died in 2013 at the age of 87.
The group is 86% owned by the Pierre Fabre Foundation.
/cloudfront-eu-central-1.images.arcpublishing.com/prisa/DIAGMBIFCBFTJADD5SB7GXXY2A.jpg)
